- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05216848
Prevalence and Risk Factors for Serious Birth Concerns in Unselected Population of Mothers (RiskfSBC)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Slovak Republic
-
Bratislava, Slovak Republic, Slovakia, 83232
- 2nd Department of Obstetrics and Gynecology, University Hospital Bratislava and Comenius University, Bratislava, Slovak Republic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- The investigators involve every nullipara and multipara giving birth at 2nd Department of Obstetrics and Gynecology, University Hospital Bratislava and Comenius University, Bratislava, Slovak Republic in a period of two years
Exclusion Criteria:
- unwilling to participate, minors (under 18 years old), high risk pregnancy, foetus mortus or perinatal death of the newborn, with slovak language, previous Caesarean section (for multipara)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
nulliparas with no existing complications in the third trimester
The investigators involve every nullipara giving birth in a period of two years. Exclusion criteria: unwilling to participate, minors (under 18 years old), high risk pregnancy, foetus mortus or perinatal death of the newborn, with slovak language |
Simple questionaire identifying the level of fear of childbirth in pregnancy
Collection of the standard clinical data during hospitalization
|
multiparas with no existing complications in the third trimester
The investigators involve every multipara giving birth in a period of two years. Exclusion criteria: unwilling to participate, minors (under 18 years old), high risk pregnancy, foetus mortus or perinatal death of the newborn, with slovak language, previous caesarean section |
Simple questionaire identifying the level of fear of childbirth in pregnancy
Collection of the standard clinical data during hospitalization
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Significant fear of childbirth
Time Frame: 15 minutes
|
Identifying the level of fear of childbirth in pregnancy by using a most widely used tool Wijma Delivery Expectancy Questionnaire
|
15 minutes
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- EC/188/2021/UNBRuzinov
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Serious Concerns
-
Christiana Care Health ServicesAlfred I. duPont Hospital for ChildrenCompleted
-
St. Joseph's Healthcare HamiltonRecruitingPerimenopause | Sexual ConcernsCanada
-
Maastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedAged | Concerns About FallingNetherlands
-
University of California, San FranciscoCompleted
-
Boston Children's HospitalThe Hospital for Sick Children; University of California, San Francisco; Children... and other collaboratorsCompletedSerious Medical Errors | Resident Sign-outUnited States, Canada
-
University of ZurichCompletedSerious Complications Following Liver ResectionSwitzerland
-
Shanghai Jiao Tong University School of MedicineCompletedEducational Problems | Serious Game | Augmented RealityChina
-
University Hospital, Basel, SwitzerlandStanley Thomas Johnson StiftungCompleted
-
University of California, DavisCompletedSubjective Cognitive Concerns (SCC)United States
-
Acibadem UniversityRecruitingVirtual Reality | Serious Game | Advanced Cardiac Life SupportTurkey
Clinical Trials on Wijma Delivery Expectancy Questionnaire
-
Aalborg UniversityTrygFonden, DenmarkCompleted
-
Centre Oscar LambretNational Cancer Institute, France; Aix Marseille Université; University of Paris... and other collaboratorsUnknownBreast Cancer | AgingFrance
-
Poitiers University HospitalCompletedPostnatal DepressionFrance
-
M.D. Anderson Cancer CenterRecruitingPancreatic Ductal AdenocarcinomaUnited States
-
Antalya Training and Research HospitalRecruiting
-
Centre Hospitalier de CayenneFoundation for Scientific Research Suriname (SWOS) Paramaribo, SurinameCompletedHIV Infections | Hepatitis B | Hepatitis C | Hepatitis D | Prevalence | EpidemiologyFrench Guiana, Suriname
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedCurrent Smoker | Former Smoker | Tobacco Use Disorder | Never Smoker | E-cig UserUnited States
-
Roswell Park Cancer InstituteNational Institute on Drug Abuse (NIDA); National Cancer Institute (NCI)CompletedCurrent Smoker | Healthy Subject | Cigarette SmokerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Metastatic Small Intestinal Adenocarcinoma | Stage IV Small Intestinal Adenocarcinoma AJCC v8United States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer... and other conditionsUnited States